Understanding and Addressing Variation in Health Care–Associated Infections After Durable Ventricular Assist Device Therapy: Protocol for a Mixed Methods Study

BACKGROUND: Durable ventricular assist device (VAD) therapy is reserved for patients with advanced heart failure who have a poor estimated 1-year survival. However, despite highly protocolized management processes, patients are at a unique risk for developing a health care–associated infection (HAI)...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:JMIR Res Protoc
Prif Awduron: Chandanabhumma, P Paul, Fetters, Michael D, Pagani, Francis D, Malani, Preeti N, Hollingsworth, John M, Funk, Russell J, Aaronson, Keith D, Zhang, Min, Kormos, Robert L, Chenoweth, Carol E, Shore, Supriya, Watt, Tessa M F, Cabrera, Lourdes, Likosky, Donald S
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: JMIR Publications 2020
Pynciau:
Protocol
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6996720/
https://ncbi.nlm.nih.gov/pubmed/31909721
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2196/14701
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg